Comparative Evaluation of Varying Doses of Dexmedetomidine for Attenuating Extubation Response in Patients Undergoing Open Cholecystectomy
International Journal of Pharmaceutical Quality Assurance · 30.04.2026 · 17 (04)
DOI: 10.25258/ijpqa.17.4.30 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.04.2026. Verfasst von Priyanka Hansda und 1 weiteren Autor:innen.
Themen: Beatmung und Weaning
Abstract (Originalsprache)
Background
Extubation can provoke significant hemodynamic and airway responses, particularly in abdominal surgeries like open cholecystectomy. Dexmedetomidine, an α2-adrenergic agonist, has been shown to attenuate these responses, but the optimal dose remains uncertain.
Aim
To compare the efficacy and safety of three different doses of dexmedetomidine (0.5 µg/kg, 0.75 µg/kg, and 1.0 µg/kg) in attenuating the extubation response in patients undergoing open cholecystectomy.
Methods
A prospective, randomized, double-blind study was conducted at the Department of Anaesthesiology, Phulo Jhano Medical College, Dumka, Jharkhand, India. A total of 84 ASA I/II patients undergoing open cholecystectomy were divided into three groups of 28. Dexmedetomidine was administered intravenously 15 minutes before extubation. Extubation quality, hemodynamic parameters, time to first rescue analgesia, and adverse events were recorded and reviewed.
Results
The doses of 0.75 µg/kg and 1.0 µg/kg improved extubation quality and hemodynamic instability compared to the dose of 0.5 µg/kg, although the highest dose of dexmedetomidine (1.0 µg/kg) was associated with greater bradycardia and hypotension. The dose of 0.75 µg/kg provides the best efficacy-safety profile.
Conclusion
Dexmedetomidine, at a dose of 0.75 µg/kg, provides the best combination of efficacy and safety in blunting extubation responses in patients having an open cholecystectomy.
Zitieren
APA
Hansda, P., & Soren, R. (2026). Comparative Evaluation of Varying Doses of Dexmedetomidine for Attenuating Extubation Response in Patients Undergoing Open Cholecystectomy. International Journal of Pharmaceutical Quality Assurance, 17(04). https://doi.org/10.25258/ijpqa.17.4.30
Vancouver
Hansda P, Soren R. Comparative Evaluation of Varying Doses of Dexmedetomidine for Attenuating Extubation Response in Patients Undergoing Open Cholecystectomy. International Journal of Pharmaceutical Quality Assurance. 2026;17(04). doi:10.25258/ijpqa.17.4.30
BibTeX
@article{Hansda2026,
author = {Hansda, Priyanka and Soren, Rani},
title = {Comparative Evaluation of Varying Doses of Dexmedetomidine for Attenuating Extubation Response in Patients Undergoing Open Cholecystectomy},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {04},
doi = {10.25258/ijpqa.17.4.30}
}
EUVIMED